- Largest supplier of influenza vaccine in U.S., first to ship, will distribute more than 60 million doses of flu vaccines for fall immunization campaigns -
National Patient Spokesperson Melanie Bloom Commemorates Significant Achievements to Raise Awareness of DVT and Potentially Fatal Complication, Pulmonary Embolism
- Bettis and Miller, Both at Risk for Anaphylaxis, Join Forces with Sanofi US to Introduce Auvi-Q (Epinephrine Injection, USP) and Serve Up Allergy-Friendly Tips for Big Game Parties -
- QIV is the next evolution of influenza vaccine designed to help protect against influenza B, a significant cause of influenza illness and associated complications across all ages, and especially children -
– CDC analysis of 10 influenza seasons indicates use of a four-strain vaccine could have prevented 2.7 million influenza cases, 21 thousand influenza-related hospitalizations and almost 1,400 influenza-related deaths(1) –
Establishment of joint project teams will leverage strengths of academic and industry cross-organizational expertise in all stages of translational research
Recent survey findings indicate majority of adults fear spreading the flu to family and friends, yet only a third of adults 18 through 64 years of age get a flu shot